Skip to main content

Advertisement

Log in

Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventory—Head and Neck Module (MDASI-HN).

Methods

Following forward and backward translation of the items of the English MDASI-HN into Italian, it was administered along with a cognitive debriefing to HNC patients able to read and understand Italian language. Individual and group responses are presented using descriptive statistics.

Results

From May 2013 through September 2013, 56 patients with HNC (18 during curative treatment, 20 in palliative chemotherapy, and 18 in follow-up period) completed the MDASI-HN followed by accompanying cognitive debriefing. Ninety-nine percent of the individual MDASI-HN items were completed. Average time to complete the MDASI-HN was 8.5 min (range 3–15). Results suggested overall ease of completion, relevance, and comprehensibleness of this translated self-report instrument in this Italian patient population.

Conclusions

The Italian version of the MDASI-HN is linguistically valid; future research should explore dimensionality, reliability, and convergent, discriminant, and predictive validity of this patient-reported instrument, in order to use this translated version in outcomes research and clinical settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ingham J, Portenoy RK (2002) The measurement of pain and other symptoms. In: Doyle D, Hanks G, Cherny N, Calman K (eds) Oxford textbook of palliative medicine, 2nd edn. Oxford University Press, New York, pp 203–219

    Google Scholar 

  2. Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 37:16–21

    Article  PubMed  Google Scholar 

  3. Kruse AL, Bredell M, Luebbers HT, Gratz KW (2010) Head and neck cancer in the elderly: a retrospective study over 10 Years (1999–2008). Head Neck Oncol 2:25

    Article  PubMed Central  PubMed  Google Scholar 

  4. Wierzbicka M, Kuśnierkiewicz M, Wójtowicz JG, Maune S, Szyfter W (2001) The quality of life in head and neck cancer patients: description of randomized examination formula based on standardized questionnaires EORTC QLQ C-30, EORTC QTQ-H-N35 and Kiel questionnaire. Otolaryngol Pol 55:287–292

    CAS  PubMed  Google Scholar 

  5. Terrell JE, Ronis DL, Fowler KE, Bradford CR, Chepeha DB, Prince ME, Teknos TN, Wolf GT, Duffy SA (2004) Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:401–408

    Article  PubMed  Google Scholar 

  6. Torres-Carranza E, Infante-Cossío P, Hernández-Guisado JM, Hens-Aumente E, Gutierrez-Pérez JL (2008) Assessment of quality of life in oral cancer. Med Oral Patol Oral Cir Bucal 13(11):E735-41

  7. Rogers SN, Ahad SA, Murphy AP (2007) A structured review and theme analysisof papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncol 43:843–868

    Article  CAS  PubMed  Google Scholar 

  8. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran DA, Bottomley A (2001) On behalf of the EORTC Quality o Life Group. EORTC QLQ-C30 Scoring Manual. Guidelines for assessing quality of life in EORTC Clinical Trials. 3 edn. EORTC, Brussels

  9. Cleeland CS, Sloan JA (2010) Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards. J Pain Symptom Manage 39(6):1077–1085

    Article  PubMed  Google Scholar 

  10. Guirimand F, Buyck JF, Lauwers-Allot E, Revnik J, Kerguen T, Aegerter P, Brasseur L, Cleeland CS (2010) Cancer-related symptom assessment in France: validation of the French M. D. Anderson symptom inventory. J Pain Symptom Manage 39(4):721–733

    Article  PubMed  Google Scholar 

  11. Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, Levin B, Link MP, Lustig C, McLaughlin J, Ried LD, Turrisi AT 3rd, Unützer J, Vernon SW (2004) National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110–1117

    Article  Google Scholar 

  12. Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008) Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26:2754–2760

    Article  PubMed  Google Scholar 

  13. Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B (2006) Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol 10:83–89

    Google Scholar 

  14. Luoma ML, Hakamies-Blomqvist L, Sjöström J, Pluzanska A, Ottoson S, Mouridsen H, Bengtsson NO, Bergh J, Malmström P, Valvere V, Tennvall L, Blomqvist C (2003) Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer. Eur J Cancer 39:1370–1376

    Article  PubMed  Google Scholar 

  15. Mehanna HM, Morton RP (2006) Patients’ views on the utility of quality of lifequestionnaires in head and neck cancer: a randomised trial. Clin Otolaryngol 31:310–316

    Article  CAS  PubMed  Google Scholar 

  16. Meeuwsen EJ, German P, Melis RJ, Adang EM, Golüke-Willemse GA, Krabbe PF, de Leest BJ, van Raak FH, Schölzel-Dorenbos CJ, Visser MC, Wolfs CA, Vliek S, Rikkert MG (2009) Cost-effectiveness of post-diagnosis treatment in dementia coordinated by Multidisciplinary Memory Clinics in comparison to treatment coordinated by general practitioners: an example of a pragmatic trial. J Nutr Health Aging 13:242–248

    Article  CAS  PubMed  Google Scholar 

  17. Kim MM, Califano JA (2004) Molecular pathology of head-and-neck cancer. Int J Cancer 112:545–553

    Article  CAS  PubMed  Google Scholar 

  18. Hilarius DL, Gundy CM, Aaronson NK (2008) Use of health-related quality-of-lifeassessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 113:628–637

    Article  PubMed  Google Scholar 

  19. Silveira AP, Gonçalves J, Sequeira T, Ribeiro C, Lopes C, Monteiro E, Pimentel FL (2010) Patient reported outcomes in head and neck cancer: selecting instruments for quality of life integration in clinical protocols. Head Neck Oncol 2:32

  20. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P (2005) Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 8(2):94–104

    Article  PubMed  Google Scholar 

  21. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle M, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson symptom inventory. Cancer 89(7):1634–1646

    Article  CAS  PubMed  Google Scholar 

  22. Rosenthal DI, Mendoza TR, Chambers MS, Asper JA, Gning I, Kies MS, Weber RS, Lewin JS, Garden AS, Ang KK, Wang S, Cleeland CS (2007) Measuring head and neck cancer symptom burden: the development and validation of the M.D. Anderson symptom inventory, head and neck module. Head Neck 29(10):923–931

    Article  PubMed  Google Scholar 

  23. Mystakidou K, Cleeland C, Tsilika E, Katsouda E, Primikiri A, Parpa E, Vlahos L, Mendoza T (2004) Greek M.D. Anderson symptom inventory: validation and utility in cancer patients. Oncology 67(3-4):203–210

    Article  PubMed  Google Scholar 

  24. Ivanova MO, Ionova TI, Kalyadina SA, Uspenskaya OS, Kishtovich AV, Guo H, Mendoza TR, Novik A, Cleeland CS, Wang XS (2005) Cancer-related symptom assessment in Russia: validation and utility of the Russian M.D. Anderson symptom inventory. J Pain Symptom Manage 30(5):443–453

    Article  PubMed  Google Scholar 

  25. Lin CC, Chang AP, Cleeland CS, Mendoza TR, Wang XS (2007) Taiwanese version of the M.D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage 33(2):180–188

    Article  PubMed  Google Scholar 

  26. Okuyama T, Wang XS, Akechi T, Mendoza TR, Hosaka T, Cleeland CS, Uchitomi Y (2003) Japanese version of the M.D. Anderson symptom inventory: a validation study. J Pain Symptom Manage 26(6):1093–1104

    Article  PubMed  Google Scholar 

  27. Wang XS, Wang Y, Guo H, Mendoza TR, Hao XS, Cleeland CS (2004) Chinese version of the M.D. Anderson symptom inventory: validation and application of symptom measurement in cancer patients. Cancer 101(8):1890–1901

    Article  PubMed  Google Scholar 

  28. Wang XS, Laudico AV, Guo H, Mendoza TR, Matsuda ML, Yosuico VD, Fragante EP, Cleeland CS (2006) Filipino version of the M.D. Anderson symptom inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage 31:542–552

    Article  PubMed  Google Scholar 

  29. Yun YH, Mendoza TR, Kang IO, You CH, Roh JW, Lee CG, Lee WS, Lee KS, Bang S-M, Cleeland CS, Wang XS (2006) Validation study of the Korean version of the M.D. Anderson symptom inventory. J Pain Symptom Manage 31(4):345–352

    Article  PubMed  Google Scholar 

  30. Gunn GB, Koukourakis MI, Mendoza TR, Cleeland CS, Rosenthal DI (2012) Linguistic validation of the Greek M.D. Anderson symptom inventory – head and neck module. For Clin Oncol 3(1):29–31

    Google Scholar 

  31. Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P, Johnson C, Ramage J, Scott N, West K, EORTC Quality of Life Group (2007) Translation procedures for standardised quality of life questionnaires: the European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 43(12):1810–1820

    Article  PubMed  Google Scholar 

  32. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcome 4:79

  33. Mear I, Giroudet C (2012) Linguistic validation procedures. In: Acquadro C, Conway K, Giroudet C, Mear I (eds) Linguistic validation manual for health outcome assessments, 2nd edn. MAPI Institute, Lyon, pp 33–117

    Google Scholar 

  34. Willis GB (2005) Cognitive interviewing: a tool for improving questionnaire design. Sage, Thousand Oaks

    Google Scholar 

  35. Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM (2004) How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol 22(17):3485–3490

    Article  PubMed  Google Scholar 

  36. Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M (2008) Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer 113(10):2704–2713

    Article  PubMed  Google Scholar 

  37. Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26(8):1355–1363

    Article  PubMed  Google Scholar 

  38. List MA, D'Antonio LL, Cella DF, Siston A, Mumby P, Haraf D, Vokes E (1996) The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer 77(11):2294–2301

    Article  CAS  PubMed  Google Scholar 

  39. Gning I, Trask PC, Mendoza TR, Harle MT, Gutierrez KA, Kitaka SA, Sherman SI, Cleeland CS (2009) Development and initial validation of the thyroid cancer module of the M. D. Anderson symptom inventory. Oncology 76:59–68

    Article  PubMed  Google Scholar 

  40. Mendoza TR, Wang XS, Lu C, Palos GR, Liao Z, Mobley GM, Kapoor S, Cleeland CS (2011) Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson symptom inventory. Oncologist 16:217–227

    Article  PubMed Central  PubMed  Google Scholar 

  41. Sailors MH, Bodurka DC, Gning I, Ramondetta LM, Williams LA, Mendoza TR, Agarwal S, Sun CC, Cleeland CS (2013) Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecoloncol 130(2):323–328

    Google Scholar 

  42. Wang XS, Williams LA, Eng C, Mendoza TR, Shah NA, Kirken-doll KJ, Shah PK, Trask PC, Palos GR, Cleeland CS (2010) Validation and application of a module of the M. D. Anderson symptom inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer 116(8):2053–2063

    Article  PubMed  Google Scholar 

  43. Henry M, Habib LA, Morrison M, Yang JW, Li XJ, Lin S, Zeitouni A, Payne R, Macdonald C, Mlynarek A, Kost K, Black M, Hier M (2013) Head and neck cancer patients want us to support them psychologically in the post treatment period: survey results. Palliat Support Care 24:1–13

    Google Scholar 

  44. van der Meulen IC, May AM, de Leeuw JR, Koole R, Oosterom M, Hordijk GJ, Ros WJ (2014) Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer 110(3):593–601

    Article  PubMed Central  PubMed  Google Scholar 

  45. Hammerlid E, Persson LO, Sullivan M, Westin T (1999) Quality-of-life effects of psychosocial intervention in patients with head and neck cancer. Otolaryngol Head Neck Surg 120(4):507–516

    Article  CAS  PubMed  Google Scholar 

  46. Rosenthal DI, Mendoza TR, Chambers MS, Burkett VS, Garden AS, Hessel AC, Lewin JS, Ang KK, Kies MS, Gring I, Wang XS, Cleeland CS (2008) The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys 72(5):1355–1361

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Bossi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Greco, A., Orlandi, E., Mirabile, A. et al. Italian version of the M.D. Anderson Symptom Inventory—Head and Neck Module: linguistic validation. Support Care Cancer 23, 3465–3472 (2015). https://doi.org/10.1007/s00520-015-2701-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2701-1

Keywords

Navigation